Sergio Lupo
Rosario, S, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Safety and efficacy of switching to bictegravir-lenacapavir versus continuing bictegravir-emtricitabine-tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
Journal: The lancet. HIV
Published: March 17, 2026
A Randomized Trial to Compare Dolutegravir Plus Boosted Darunavir Versus Recommended Standard of Care Antiretroviral Regimens in People With HIV-1, Whose First-line Non-nucleoside Reverse Transcriptase Inhibitor Therapy Has Failed: Final 96-week Results of the D2EFT Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 01, 2025
VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Antidrug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study Results.
Journal: The Journal of infectious diseases
Published: March 14, 2025
A small cluster randomised clinical trial to improve health outcomes among Argentine patients disengaged from HIV care.
Journal: Lancet regional health. Americas
Published: October 10, 2022
Correction to: Cumulative Burden of Mental Health Factors and Engagement in HIV Care in Argentina.
Journal: International journal of behavioral medicine
Published: January 27, 2021
Cumulative Burden of Mental Health Factors and Engagement in HIV Care in Argentina.
Journal: International journal of behavioral medicine
Published: July 30, 2020
Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health.
Journal: AIDS (London, England)
Published: December 15, 2017
Undifferentiated Pleomorphic Sarcoma and the Importance of Considering the Oncogenic and Immune-Suppressant Role of the Human T-Cell Lymphotropic Virus Type 1: A Case Report.
Journal: Frontiers in oncology
Published: February 14, 2017
Assessing endocrine and immune parameters in human immunodeficiency virus-infected patients before and after the immune reconstitution inflammatory syndrome.
Journal: Archives of endocrinology and metabolism
Published: December 21, 2016
A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results.
Journal: HIV clinical trials
Published: May 18, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026